Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
Aaron Burmeister(Düsseldorf University Hospital), Daniel Nettersheim(University of Bonn)
Cited by 25
Related Papers
The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas
|British Journal of Cancer|2016|63
SOX2 is essential for <i>in vivo</i> reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate
|Oncotarget|2016|56